Trial Profile
An Investigator-Initiated Study to Assess the Degree of Irritation After a Second Cycle of Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Jun 2015
Price :
$35
*
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Actinic keratosis
- Focus Adverse reactions
- 07 Jan 2014 Status changed from recruiting to completed ClinicalTrials.gov record.
- 01 May 2013 New trial record